Clinical Trial Update: Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating lofexidine in combination with buprenorphine to reduce PTSD symptoms and relapse in veterans with opioid use disorder, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | Conditions: Post Traumatic Stress Disorder, Opioid-use Disorder | Phase 2 | Status: RECRUITING